Ceva-Phylaxia inaugurates EUR 25 mln vaccine plant
French-owned veterinary health company Ceva-Phylaxia inaugurated a EUR 25 million vaccine plant in Budapest on Wednesday, according to state news wire MTI.
The investment will increase annual production capacity at its base in the capital by a factor of six to 3 million units.
The expansion will create 60 jobs, said Ceva Group Chairman-CEO Marc Prikazsky. Ceva has invested about EUR 100 mln in Hungary, he added.
"In the case of Ceva-Phylaxia, innovation is indeed coupled with results, and Iʼve already made a note in my diary to be here with you again in 2020, or even sooner, to inaugurate our next facility," Prikazsky said.
Ceva-Phylaxiaʼs revenue is expected to exceed HUF 20 billion this year, said Country Manager Péter Kozák. Exports generate about HUF 16 bln of that amount.
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.